Cargando…
Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome
Two infants with retinoblastoma and 13q syndrome with multiorgan system anomalies were treated with targeted intra-arterial chemotherapy (IAC) using one-to-three cycles of melphalan 5 mg to avoid systemic chemotherapeutic side effects. Both patients showed good response, with tumor control and no sy...
Autores principales: | Dillon, Alexander B., Douglass, Alexzandra, Jabbour, Pascal, Shields, Carol L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5084500/ https://www.ncbi.nlm.nih.gov/pubmed/27843232 http://dx.doi.org/10.4103/0974-620X.192278 |
Ejemplares similares
-
Update on Intra-Arterial Chemotherapy for Retinoblastoma
por: Zanaty, Mario, et al.
Publicado: (2014) -
Retinoblastoma in a 23-year-old adult treated with primary intra-arterial and intravitreal chemotherapy
por: McMahon, Jeffrey F., et al.
Publicado: (2019) -
Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras
por: Selzer, Evan B, et al.
Publicado: (2019) -
Intra-arterial chemotherapy in retinoblastoma – A paradigm change
por: Manjandavida, Fairooz P, et al.
Publicado: (2019) -
Retinoblastoma regression following intra-arterial chemotherapy to the contralateral eye
por: Su, Grace L., et al.
Publicado: (2019)